Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025TheranosticsOpen Access

On the dilemma of using single EV analysis for liquid biopsy: the challenge of low abundance of tumor EVs in blood

View Full Paper
Ask AI
Bookmark
Share

Authors

MIMeruyert ImanbekovaMSMohul SharmaSWSebastian Wachsmann‐Hogiu

Discussion

Loading...

Member takes

Overview

This review highlights low abundance of tumor EVs in blood, indicating the need for better isolation and analysis methods.

Key Points

  • Single extracellular vesicle analysis has potential for improving cancer diagnostics but faces significant technical challenges.
  • Low abundance of tumor-derived EVs makes up less than 0.1% of total EVs in blood samples, impacting detection rates.
  • To enhance diagnostic accuracy, the study suggests better tEVs isolation methods and high-throughput analysis techniques.
  • Improving these methods may advance liquid biopsy applications and personalized treatment strategies for cancer patients.

Cite This Study

Imanbekova et al. (2025) studied this question.

synapsesocial.com/papers/68c1b19954b1d3bfb60e8efehttps://doi.org/10.7150/thno.115131
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Molecular Analysis of Single Tumor-Derived Extracellular Vesicles with Improved Robustness and Accuracy2026
  2. 2Unlocking the diagnostic potential of extracellular vesicles in cancer2025
  3. 3Unlocking the Diagnostic Potential of Extracellular Vesicles in Cancer.2026
  4. 4Extracellular Vesicles as Diagnostic Biomarkers in Cancer: From Technological Advances to Clinical Translation2025 · 1 citations
  5. 5Stoichiometric constraints for detection of EV-borne biomarkers in blood2024 · 1 citations